GENF.L
Genflow Biosciences plc operates as a biotechnology company that focuses on developing biological interventions aimed at tackling the effects of ageing, slowing or halting the ageing process, and reducing the incidence of age-related diseases with increase in health span. Its lead compound is GF-1002, a suspension of an adeno-associated viral vector-based gene therapy for intravenous infusion. The company is also developing GF-3001, a topical delivery of SIRT6 to the skin; and GF-4001, a non-human pipeline anti-aging for veterinary use. The company was incorporated in 2021 and is headquartered in London, the United Kingdom.
Industry
Biotechnology
IPO Date
2022-01-17
Stock Exchange
LSE
Ticker
GENF.L
According to Genflow Biosciences plc’s latest financial reports and current stock price. The company's current ROE is -105.34%. This represents a change of 60.59% compared to the average of -65.59% of the last 4 quarters.
The mean historical ROE of Genflow Biosciences plc over the last ten years is -592.74%. The current -105.34% ROE has changed -82.23% with respect to the historical average. Over the past ten years (40 quarters), GENF.L's ROE was at its highest in in the March 2021 quarter at 0%. The ROE was at its lowest in in the December 2023 quarter at -138.74%.
Average
-592.74%
Median
-260.83%
Minimum
-1792.86%
Maximum
-56.43%
Discovering the peaks and valleys of Genflow Biosciences plc ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 503.06%
Maximum Annual ROE = -56.43%
Minimum Annual Increase = -96.85%
Minimum Annual ROE = -1792.86%
| Year | ROE | Change |
|---|---|---|
| 2023 | -224.37% | 297.62% |
| 2022 | -56.43% | -96.85% |
| 2021 | -1792.86% | 503.06% |
The current ROE of Genflow Biosciences plc (GENF.L) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-691.22%
5-year avg
-592.74%
10-year avg
-592.74%
Genflow Biosciences plc’s ROE is greater than IXICO plc (-14.21%), greater than Nuformix plc (-477.73%), greater than Futura Medical plc (-104.83%), greater than OptiBiotix Health Plc (-2.27%), greater than Verici Dx plc (-178.37%), less than Cizzle Biotechnology Holdings Plc (1.16%), greater than Oxford BioDynamics Plc (-316.67%), greater than GENinCode plc (-262.16%), greater than CRISM Therapeutics Corporation (-79.01%), greater than Tissue Regenix Group plc (-3.91%),
| Company | ROE | Market cap |
|---|---|---|
| -14.21% | N/A | |
| -477.73% | N/A | |
| -104.83% | N/A | |
| -2.27% | N/A | |
| -178.37% | N/A | |
| 1.16% | N/A | |
| -316.67% | N/A | |
| -262.16% | N/A | |
| -79.01% | N/A | |
| -3.91% | N/A |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Genflow Biosciences plc using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Genflow Biosciences plc or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the ROE?
How can you use the ROE?
What is Genflow Biosciences plc's ROE?
How is the ROE calculated for Genflow Biosciences plc (GENF.L)?
What is the highest ROE for Genflow Biosciences plc (GENF.L)?
What is the 3-year average ROE for Genflow Biosciences plc (GENF.L)?
What is the 5-year average ROE for Genflow Biosciences plc (GENF.L)?
How does the current ROE for Genflow Biosciences plc (GENF.L) compare to its historical average?